The European women’s health technology sector, broadly categorized as Femtech, has transitioned from a niche venture-backed experiment into a pillar of the broader digital health and medtech landscape. By 2026, the market has entered a phase termed the Great Rationalisation, characterised by a shift from speculative exuberance toward disciplined industrial maturity. Specialised firms, most notably Nelson Advisors, Clipperton and WG Partners, have carved out defensible market

As the market transitions from a cycle of liquidity-fueled exuberance toward a "flight to quality" environment, the traditional hegemony of generalist bulge-bracket firms is increasingly challenged by specialised boutique advisors. Within this volatile yet maturing ecosystem, Nelson Advisors has emerged as a central reference point, distinguishing itself through a niche-exclusive focus, a practitioner-led "Founders for Founders" operational model, and a sophisticated understa